These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 32868555)

  • 1. Organoid Models of Colorectal Pathology: Do They Hold the Key to Personalized Medicine? A Systematic Review.
    DeHaan RK; Sarvestani SK; Huang EH
    Dis Colon Rectum; 2020 Nov; 63(11):1559-1569. PubMed ID: 32868555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Organoid Culture of Isolated Cells from Patient-derived Tissues with Colorectal Cancer.
    Xie BY; Wu AW
    Chin Med J (Engl); 2016 Oct; 129(20):2469-2475. PubMed ID: 27748340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling colorectal cancer: A bio-resource of 50 patient-derived organoid lines.
    Engel RM; Jardé T; Oliva K; Kerr G; Chan WH; Hlavca S; Nickless D; Archer SK; Yap R; Ranchod P; Bell S; Niap A; Koulis C; Chong A; Wilkins S; Dale TC; Hollins AJ; McMurrick PJ; Abud HE
    J Gastroenterol Hepatol; 2022 May; 37(5):898-907. PubMed ID: 35244298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient-Derived Organoids of Cholangiocarcinoma.
    Maier CF; Zhu L; Nanduri LK; Kühn D; Kochall S; Thepkaysone ML; William D; Grützmann K; Klink B; Betge J; Weitz J; Rahbari NN; Reißfelder C; Schölch S
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Organoids as a Robust Preclinical Model for Precision Medicine in Colorectal Cancer: A Systematic Review.
    Flood M; Narasimhan V; Wilson K; Lim WM; Ramsay R; Michael M; Heriot A
    Ann Surg Oncol; 2022 Jan; 29(1):47-59. PubMed ID: 34596795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling colorectal cancers using multidimensional organoids.
    Sayed IM; El-Hafeez AAA; Maity PP; Das S; Ghosh P
    Adv Cancer Res; 2021; 151():345-383. PubMed ID: 34148617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deciphering the Tumor Microenvironment of Colorectal Cancer and Guiding Clinical Treatment With Patient-Derived Organoid Technology: Progress and Challenges.
    Li J; Liu J; Xia W; Yang H; Sha W; Chen H
    Technol Cancer Res Treat; 2024; 23():15330338231221856. PubMed ID: 38225190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical models as patients' avatars for precision medicine in colorectal cancer: past and future challenges.
    Durinikova E; Buzo K; Arena S
    J Exp Clin Cancer Res; 2021 Jun; 40(1):185. PubMed ID: 34090508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mimicking Tumor Cell Heterogeneity of Colorectal Cancer in a Patient-derived Organoid-Fibroblast Model.
    Atanasova VS; de Jesus Cardona C; Hejret V; Tiefenbacher A; Mair T; Tran L; Pfneissl J; Draganić K; Binder C; Kabiljo J; Clement J; Woeran K; Neudert B; Wohlhaupter S; Haase A; Domazet S; Hengstschläger M; Mitterhauser M; Müllauer L; Tichý B; Bergmann M; Schweikert G; Hartl M; Dolznig H; Egger G
    Cell Mol Gastroenterol Hepatol; 2023; 15(6):1391-1419. PubMed ID: 36868311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective derivation of a living organoid biobank of colorectal cancer patients.
    van de Wetering M; Francies HE; Francis JM; Bounova G; Iorio F; Pronk A; van Houdt W; van Gorp J; Taylor-Weiner A; Kester L; McLaren-Douglas A; Blokker J; Jaksani S; Bartfeld S; Volckman R; van Sluis P; Li VS; Seepo S; Sekhar Pedamallu C; Cibulskis K; Carter SL; McKenna A; Lawrence MS; Lichtenstein L; Stewart C; Koster J; Versteeg R; van Oudenaarden A; Saez-Rodriguez J; Vries RG; Getz G; Wessels L; Stratton MR; McDermott U; Meyerson M; Garnett MJ; Clevers H
    Cell; 2015 May; 161(4):933-45. PubMed ID: 25957691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Organoid models of gastrointestinal cancers in basic and translational research.
    Lau HCH; Kranenburg O; Xiao H; Yu J
    Nat Rev Gastroenterol Hepatol; 2020 Apr; 17(4):203-222. PubMed ID: 32099092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What role could organoids play in the personalization of cancer treatment?
    Francies HE; Garnett MJ
    Pharmacogenomics; 2015; 16(14):1523-6. PubMed ID: 26485224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient-derived cancer modeling for precision medicine in colorectal cancer: beyond the cancer cell line.
    Pyo DH; Hong HK; Lee WY; Cho YB
    Cancer Biol Ther; 2020 Jun; 21(6):495-502. PubMed ID: 32208894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of biomechanics on colorectal organoid culture].
    Qian X; Sun X; Liang Y; Yang L
    Sheng Wu Gong Cheng Xue Bao; 2024 May; 40(5):1309-1322. PubMed ID: 38783799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient-derived organoids as a preclinical platform for precision medicine in colorectal cancer.
    Cho YW; Min DW; Kim HP; An Y; Kim S; Youk J; Chun J; Im JP; Song SH; Ju YS; Han SW; Park KJ; Kim TY
    Mol Oncol; 2022 Jun; 16(12):2396-2412. PubMed ID: 34850547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Organoid-based personalized medicine: from tumor outcome prediction to autologous transplantation.
    Soto-Gamez A; Gunawan JP; Barazzuol L; Pringle S; Coppes RP
    Stem Cells; 2024 Jun; 42(6):499-508. PubMed ID: 38525972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Personalized Proteome Profiles of Healthy and Tumor Human Colon Organoids Reveal Both Individual Diversity and Basic Features of Colorectal Cancer.
    Cristobal A; van den Toorn HWP; van de Wetering M; Clevers H; Heck AJR; Mohammed S
    Cell Rep; 2017 Jan; 18(1):263-274. PubMed ID: 28052255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stem Cells and Organoid Technology in Precision Medicine in Inflammation: Are We There Yet?
    Tran F; Klein C; Arlt A; Imm S; Knappe E; Simmons A; Rosenstiel P; Seibler P
    Front Immunol; 2020; 11():573562. PubMed ID: 33408713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Harnessing the Biology of Canine Intestinal Organoids to Heighten Understanding of Inflammatory Bowel Disease Pathogenesis and Accelerate Drug Discovery: A One Health Approach.
    Kopper JJ; Iennarella-Servantez C; Jergens AE; Sahoo DK; Guillot E; Bourgois-Mochel A; Martinez MN; Allenspach K; Mochel JP
    Front Toxicol; 2021; 3():773953. PubMed ID: 35295115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preserved genetic diversity in organoids cultured from biopsies of human colorectal cancer metastases.
    Weeber F; van de Wetering M; Hoogstraat M; Dijkstra KK; Krijgsman O; Kuilman T; Gadellaa-van Hooijdonk CG; van der Velden DL; Peeper DS; Cuppen EP; Vries RG; Clevers H; Voest EE
    Proc Natl Acad Sci U S A; 2015 Oct; 112(43):13308-11. PubMed ID: 26460009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.